Previous 10 | Next 10 |
Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Merit Medical Systems, Inc. (“Merit” or the “Company”) (Nasdaq: MMSI ). Merit manufactures and markets disposable medical devices...
Merit Medical Systems (NASDAQ: MMSI ): Q4 Non-GAAP EPS of $0.40 beats by $0.06 ; GAAP EPS of -$0.08 misses by $0.19 . More news on: Merit Medical Systems, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
Q4 2019 worldwide revenue of $257.9 million, up 10.6% as reported over Q4 2018 Q4 2019 core revenue on a comparable, constant currency basis* up 8.5% over Q4 2018 Q4 2019 GAAP loss per share was $(0.08), compared to GAAP EPS of $0.16 in Q4 2018 Q4 2019 non-GAAP EPS* was $0.40, compared...
Merit Medical ( MMSI +0.9% ) announces the following regulatory approvals of devices it owns or has the rights to distribute: More news on: Merit Medical Systems, Inc., Healthcare stocks news, Read more ...
SOUTH JORDAN, Utah, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that regulatory clearances have been issued with res...
SOUTH JORDAN, Utah, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical ca...
SOUTH JORDAN, Utah, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced today that it will release its financial results for the f...
Bluebird bio (NASDAQ: BLUE ) initiated with Buy rating and $120 (56% upside) price target at Bank of America. Upgraded to Outperform with a $100 price target at Evercore ISI. Shares up 2% premarket. More news on: bluebird bio, Inc., Centene Corporation, Myovant Sciences Ltd., H...
New York, New York--(Newsfile Corp. - January 30, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Merit Medical Systems, Inc. (NASDAQ: MMSI) ("Merit Medical" or the "Company") of the February 3, 2020 deadline to seek the role of lead plaintiff i...
SAN DIEGO, CA / ACCESSWIRE / January 28, 2020 / The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in Merit Medical Systems, Inc. (NYSE:MMSI) shares. Investors, who purchased shares of Merit Medical Systems, Inc. (NYSE:MMSI), have certain options and ...
News, Short Squeeze, Breakout and More Instantly...
Merit Medical Systems Inc. Company Name:
MMSI Stock Symbol:
NASDAQ Market:
Merit Medical Systems Inc. Website:
Asset acquisition expands Merit’s endoscopy portfolio with a minimally invasive solution for patients suffering from chronic gastroesophageal reflux disease (GERD). Asset acquisition projected to add approximately $30 million of revenue, on an annualized basis, in key gastroint...
2024-06-23 06:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SOUTH JORDAN, Utah, June 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended June 30, 2024, after the close of the stock marke...